
Sign up to save your podcasts
Or


Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
By Mayo Clinic4.4
276276 ratings
Guest: Aaron M. Potretzke, M.D. (@potretzke)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient’s risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions.
Specific topics:
Additional resources:
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

319 Listeners

705 Listeners

506 Listeners

298 Listeners

260 Listeners

895 Listeners

3,360 Listeners

1,152 Listeners

517 Listeners

373 Listeners

12 Listeners

18 Listeners

15 Listeners

9 Listeners

257 Listeners

439 Listeners

313 Listeners

45 Listeners

14 Listeners

327 Listeners

268 Listeners